IperionX Limited (IPX) Stock Price & Analysis
IperionX Limited (IPX) closed at USD 16.54 on Monday, November 9, 2026, up 17.30% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 14.1; the Nov 9, 2026 session ranged USD 14.96–16.83 on volume of 328,091 shares. Market capitalization is $599.15M, with a 52-week range of USD 12.14–61.45 (NCM). Source: Nexqual, retrieved November 10, 2026 at 07:56 UTC.
What changed for IPX since Aug 31, 2025
The built-in knowledge of several widely used AI models ends around Aug 31, 2025. Everything below is newer, dated and sourced (as of Nov 9, 2026).
- IperionX Limited (IPX) stock went from USD 44.32 (close of the week of Aug 25, 2025, split-adjusted) to USD 16.54, a -62.7% price change; the S&P 500 (SPY) moved +18.3% over the same period.
- Analyst actions on IPX in the last 120 days: 2 (0 upgrades or target raises, 1 downgrades or target cuts); most recent B. Riley Securities, Sep 30, 2026.
Also available as compact Markdown for AI agents: nexqual.com/IPX.md
Key facts (IPX)
- Insider open-market purchases, last ~7 months: 4 Form 4 filings, $4.9M; 0 by opportunistic insiders, 0 by routine insiders.
- Analysts: Buy (mean 2.00 on a 1–5 scale) (6 analysts), mean target USD 40.2 (range 26–55).
- Total return with dividends: 1Y -56.5% vs S&P 500 +11.7%; 5Y +171.7% vs S&P 500 +72.2%.
- Dividend: IPX paid no cash dividend in the last five years.
- Short interest: 4.63% of float (as of 2026-10-15), 3.8 days to cover.
Insider purchases (SEC Form 4, open-market, last ~7 months) (IPX)
4 purchases, $4.9M. Private placements, offerings, dividend reinvestment and employee stock purchase plan buys are excluded.
| Trade date | Insider | Role | Shares | Value | Avg price | Insider type |
|---|---|---|---|---|---|---|
| 2026-07-10…2026-07-13 | Hannigan Todd | Executive Chairman | 525,000 | $1.9M | 3.58 | Too little history (no open-market trades in 2023–2025) |
| 2026-07-10 | Arima Anastasios | Chief Executive Officer | 138,720 | $497K | 3.58 | Too little history (no open-market trades in 2023–2025) |
| 2026-04-28…2026-04-29 | Hannigan Todd | Executive Chairman | 480,000 | $2.1M | 4.33 | Too little history (no open-market trades in 2023–2025) |
| 2026-04-28 | Arima Anastasios | Chief Executive Officer | 110,000 | $494K | 4.49 | Too little history (no open-market trades in 2023–2025) |
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Analysts (IPX)
Consensus Buy (mean 2.00 on a 1–5 scale), 6 analysts; mean target USD 40.2 (low 26, high 55).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-30 | B. Riley Securities | Target lowered | Buy | $52 → $34 |
| 2026-09-02 | Jefferies | Initiated | Buy | $26 |
Total return (dividends reinvested) (IPX)
| 1Y (from 2025-11-10) | 5Y (from 2022-06-20) | |
|---|---|---|
| Total return | -56.5% | +171.7% |
| S&P 500 (SPY) | +11.7% | +72.2% |
| Per year | -56.6% | +25.6% |
| Volatility (annualized) | 86.6% | 75.7% |
| Max drawdown | -79.3% (Jan 2026→Oct 2026) | -79.3% (Jan 2026→Oct 2026) |
Dividends (IPX)
IPX paid no cash dividend in the last five years.
Short interest (IPX)
1,445,771 shares sold short, 4.63% of the float, as of Oct 15, 2026 (exchange short-interest report, published about twice a month). Prior report (Sep 15, 2026): 916,942 shares (+57.7%). Days to cover: 3.8 (short shares ÷ average daily volume).
IPX recent SEC filings (last 120 days)
| Filed | Form | What it says |
|---|---|---|
| Oct 29, 2026 | 6-K | Current report (foreign issuer) · period ended Oct 29, 2026 |
| Oct 15, 2026 | 6-K | Current report (foreign issuer) · period ended Oct 15, 2026 |
| Sep 29, 2026 | 20-F | Annual report (foreign issuer) · period ended Jun 30, 2026 |
| Sep 29, 2026 | 6-K | Current report (foreign issuer) · period ended Sep 29, 2026 |
| Sep 16, 2026 | 6-K | Current report (foreign issuer) · period ended Sep 16, 2026 |
| Aug 31, 2026 | 6-K | Current report (foreign issuer) · period ended Aug 31, 2026 |
| Aug 3, 2026 | 6-K | Current report (foreign issuer) · period ended Aug 3, 2026 |
| Jul 30, 2026 | 6-K | Current report (foreign issuer) · period ended Jul 30, 2026 |
Source: SEC EDGAR. Quotes are the opening words of each item as filed; each form links to the filing. Insider Form 4 filings are listed in the insider sections.
IPX suppliers, customers and competitors (named in its 20-F)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Customer | Ford (F) | “Programs with Ford and consumer-electronics customers demonstrate the flexibility of the platform to supply both titanium powder and manufactured components.” |
Quoted from the company's 20-F filed Sep 29, 2026.
IPX analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | — | — | — | $0 | — |
| Next quarter (ends Dec 2026) | — | — | — | $0 | — |
| Current fiscal year (ends Jun 2027) | — | — | — | $7.9M | — |
| Next fiscal year (ends Jun 2028) | $1.53 | $0.25 | +512.0% | $103.2M | 1 |
IPX options: expected move
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Nov 20, 2026 | 11 | 100.4% | ±14.8% |
| Dec 18, 2026 | 39 | 85.8% | ±23.2% |
| Jan 15, 2027 | 67 | 77.5% | ±27.2% |
| Apr 16, 2027 | 158 | 71.8% | ±37.2% |
30-day implied volatility 83.9% vs 101.5% realized over the last 30 trading days. Put/call ratio (volume) 4.33. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of November 10, 2026 at 07:56 UTC)
| Price | USD 16.54 |
|---|---|
| Change | ▲ 17.30% (up) |
| Previous Close | USD 14.1 |
| Open | USD 15.01 |
| Day Range | USD 14.96 – 16.83 |
| 52-Week Range | USD 12.14 – 61.45 |
| Volume | 328,091 shares |
| Market Cap | $599.15M |
| Exchange | NCM |
Technical Analysis (IPX)
Nexqual's technical model rates IPX "SELL" based on 2 bullish and 4 bearish signals across 127 daily candles, as of November 10, 2026 at 07:56 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 53.44 (neutral) |
| vs SMA50 | Below (USD 17.2) |
| MACD | -0.49 (negative) |
Analyst Ratings (IPX)
Wall Street analysts rate IPX "Buy" based on 6 analysts, with a mean price target of USD 40.2 (range USD 26–55), per Nexqual as of November 10, 2026 at 07:56 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 6 |
| Mean Target | USD 40.2 |
| High Target | USD 55 |
| Low Target | USD 26 |
| Buy / Hold / Sell | 6 / 0 / 0 |
Earnings (IPX)
| Revenue Estimate | $0 |
|---|
Source: Nexqual, November 10, 2026 at 07:56 UTC.
Financials & Fundamentals (IPX)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| ROE | -73.88% |
| Debt / Equity | 0.05 |
| Current Ratio | 3.24 |
| Total Cash | $35.24M |
| Total Debt | $4.16M |
Source: Nexqual, November 10, 2026 at 07:56 UTC.
Financial Health Score (IPX)
Nexqual rates IperionX Limited's overall financial health "Mixed" across five dimensions, as of November 10, 2026 at 07:56 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Strong — $35M cash vs $4M debt, net cash position |
| Cash Flow | Weak — Operating cash flow -$45M (TTM) |
| Efficiency | Critical — ROE -74%, ROA -41.3% |
Ownership (IPX)
| Insider Ownership | +0.09% |
|---|---|
| Institutional Ownership | +17.11% |
| Shares Outstanding | 36.22M |
| Float | 30.84M |
| Short % of Float | +4.63% |
Source: Nexqual, November 10, 2026 at 07:56 UTC.
Leadership (IPX)
IperionX Limited is led by Anastasios Arima B.Com., Founder, MD, CEO & Executive Director, per Nexqual as of November 10, 2026 at 07:56 UTC.
| Founder, MD, CEO & Executive Director | Anastasios Arima B.Com. |
|---|---|
| Executive Chairman | Todd William Hannigan B. Eng (Hons), B.E. |
| President & Chief Strategy Officer | Toby Edgcumbe Symonds |
| Co-founder & Chief Operating Officer | W. Scott Sparks |
| Chief Financial Officer | Marcela Rocha Barbosa De Castro |
Major Backers & Investors (IPX)
Notable institutional backers of IperionX Limited include Van Eck Associates Corporation, VanEck ETF Trust-VanEck Rare Earth and Strategic Metals ETF, Woodline Partners LP, according to Nexqual as of November 10, 2026 at 07:56 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Van Eck Associates Corporation | 4.46% |
| VanEck ETF Trust-VanEck Rare Earth and Strategic Metals ETF | 3.07% |
| Woodline Partners LP | 1.81% |
| Millennium Management | 1.6% |
| Stifel Financial Corporation | 1.45% |
| Old West Investment Management, LLC | 0.95% |
| Fidelity | 0.85% |
| Franklin Strategic Series-FRANKLIN SMALL CAP GROWTH FUND | 0.65% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| State Street | 0.95% |
Source: Nexqual, November 10, 2026 at 07:56 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NEXA | Nexa Resources S.A. | USD 12.04 | ▲ 5.61% |
| SSMR | Sunshine Silver Mining & Refini | USD 14.8 | ▲ 11.53% |
| ALM | Almonty Industries Inc. | USD 8.78 | ▲ 8.07% |
| USAR | USA Rare Earth, Inc. | USD 8.76 | ▲ 6.5% |
| SKE | Skeena Resources Limited | USD 32.71 | ▲ 5.75% |
| MTRN | Materion Corporation | USD 202.14 | ▲ 8.61% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: November 10, 2026 at 07:56 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt